aip-20230504
FALSE000166701100016670112023-05-042023-05-04

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (date of earliest event reported): May 4, 2023
 
ARTERIS, INC.
(Exact name of Registrant, as specified in its charter)
Delaware001-4096027-0117058
(State or other jurisdiction of incorporation)(Commission File Number)(I.R.S. Employer Identification Number)

595 Millich Dr. Suite 200
Campbell, CA
95008
(Address of principal executive offices)(Zip Code)
(408) 470-7300
(Registrant's telephone number, including area code)

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class Trading
Symbol(s)
 Name of each exchange
on which registered
Common Stock, $0.001 par value per share AIP The Nasdaq Stock Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 1.02 Termination of a Material Definitive Agreement

On May 4, 2023, Arteris, Inc. (the “Company”) and Jefferies LLC (“Jefferies”) mutually terminated the Sale Agreement between the parties dated November 8, 2022. The Sale Agreement provided that the Company may sell shares of its common stock, from time to time, for up to $50,000,000 in aggregate sales proceeds, through an “at the market” equity offering program under which Jefferies acted as sales agent. No shares of the Company’s common stock were sold under the Sale Agreement that has been terminated.

The foregoing description of the Sale Agreement is not complete and is qualified in its entirety by reference to the full text of the Sale Agreement, a copy of which is filed as Exhibit 1.2 to the Company’s Registration Statement on Form S-3 filed with the Securities and Exchange Commission (the “SEC”) on November 8, 2022.

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 9, 2023   

 
   
 By:/s/ Nicholas B. Hawkins
 Name:Nicholas B. Hawkins
 Title:Vice President and Chief Financial Officer

3